PRI analysis suggests billions in savings via biosimilars
A new Pacific Research Institute study estimates that state employee health plans could save up to $1.8 billion annually by expanding the use of lower-cost biosimilar medicines.
A new Pacific Research Institute study estimates that state employee health plans could save up to $1.8 billion annually by expanding the use of lower-cost biosimilar medicines.
The Annual Trend Report highlights the rise of fiber, liver health, supplement transparency, trademarked ingredients, and flavor innovation as top consumer trends for 2026.
Demand is being driven by rising awareness of gut microbiome health, increased preventive health spending and growing consumer interest in targeted dietary solutions.
North America will stay a leading wellness market with high consumer spending on premium health products, digital health, and preventive care.
The US drives growth via branded therapies, rising obesity, and broader use in diabetes and weight management.
The study found that shoppers are increasingly drawn to store brands for reasons beyond value.
Value consciousness, treatment‑led demand, and digital acceleration shape performance.
Over a quarter of Millennial parents (27%) will spend over $500 per child, yet over half (51%) say long lines in-store cause them to walk away without completing their purchase.
The pullback in spending, Deloitte found, reflects a mix of cost pressures and caution amid a higher cost of living.
This shift directly impacts purchasing decisions, with consumers altering their baskets to align with new dietary preferences.
Convenience and cost-cutting outweigh privacy concerns for most online consumers.
The results highlight the financial pressures shaping buying decisions and the operational priorities retailers must address.
51% of consumers seeking to add protein to their diets are women.
U.S. prestige beauty market grew by 2% to $16 billion, while sales at mass merchants increased 4% to $34.6 billion in first half of 2025.